Beurer
Söflinger Straße 218, Ulm, Baden-Württemberg, 89077, Germany
Overview
Beurer provides german engineering products for health care, family welfare and exclusive line ELLE.
- Total investments
- 2
- Lead investments
- 1
- Investments · 12mo
- 1
- Active investors
- 0
Sector focus
- E-Commerce
- Health Care
- Sporting Goods
Investment portfolio
- Gardia
Participated · Series A · Feb 2026
Gardia has developed a healthtech solution centered on a lightweight wristband that automatically detects falls and triggers an emergency response for older adults whether they are at home or on the go, eliminating the need for a paired smartphone. All hardware, software, application components, and AI algorithms are built in-house to maximize detection accuracy and usability for seniors. The product already serves a five-figure active user base across the DACH region, boasting strong user retention and reimbursement agreements with German health insurers. By addressing the stigma and complexity associated with traditional emergency buttons, Gardia aims to increase everyday adoption and improve outcomes when falls occur. The company is positioning itself as an independent safety platform at a time when Europe’s aging population is creating significant strain on healthcare resources. Fresh capital will finance further geographic expansion within DACH and into other international markets, while also deepening B2B partnerships in the care and healthcare sectors. The Series A round underscores investor confidence in Gardia’s technology, traction, and scalable go-to-market model.
- PKVitality
Led · Equity · Jan 2020
PKvitality is a Paris-based bio-wearable startup founded in 2017 developing K’Watch, a painless smartwatch continuous glucose monitoring (CGM) device. K’Watch uses a consumable called K’apsul and SkinTaste technology—an array of biochemical sensors with micro‑points that contact interstitial fluid in the upper skin layer to measure glucose without blood. The company is also developing K’Watch Athlete to provide real‑time lactic acid monitoring for athletes. PKvitality reports strong preclinical results and aims to reach a First in Man milestone. It secured €2.25 million from an agreement with Beurer GmbH; the funds will support continued development and validation. Beurer has acquired exclusive commercialisation rights for Germany, Austria and Italian tenders and agreed a sales volume that will significantly contribute to PKvitality’s commercial volume.
Team
No current team members are available.